HZNP logo

Horizon Therapeutics Public Limited Company Ordinary Shares

HZNP

HZNP: Horizon Therapeutics PLC is a biotechnology company. The company is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Some of its pipeline products include UPLIZNA; HZN-825; Dazodalibep; Daxdilimab; TEPEZZA and others.

more

Show HZNP Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of HZNP by members of U.S. Congress

Politician Type Traded
Daniel Goldman House / D Sale $15,001 - $50,000 Jan. 31, 2023
Thomas Macarthur House / R Sale $1,001 - $15,000 May. 27, 2015
Thomas Macarthur House / R Purchase $1,001 - $15,000 May. 26, 2015
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by HZNP's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Procedure for the preparation of 4-phenyl butyrate and uses thereof May. 25, 2021
  • Patent Title: Treatment of urea cycle disorders in neonates and infants Jun. 02, 2020
  • Patent Title: Procedure for the preparation of 4-phenyl butyrate and uses thereof Jun. 25, 2019
  • Patent Title: Methods of therapeutic monitoring of nitrogen scavenging drugs Jan. 22, 2019
  • Patent Title: Methods of therapeutic monitoring of nitrogen scavenging drugs Jan. 22, 2019
  • Patent Title: Methods of therapeutic monitoring of nitrogen scavenging drugs Jan. 22, 2019
  • Patent Title: Methods of therapeutic monitoring of nitrogen scavenging drugs Jan. 22, 2019
  • Patent Title: Methods of therapeutic monitoring of nitrogen scavenging drugs Jan. 22, 2019
  • Patent Title: Methods of therapeutic monitoring of nitrogen scavenging drugs Aug. 14, 2018
  • Patent Title: Methods of therapeutic monitoring of nitrogen scavenging drugs Aug. 14, 2018
  • Patent Title: Methods of therapeutic monitoring of nitrogen scavenging drugs Jun. 19, 2018
  • Patent Title: Methods of therapeutic monitoring of nitrogen scavenging drugs May. 08, 2018
  • Patent Title: Methods of therapeutic monitoring of nitrogen scavenging drugs May. 08, 2018
  • Patent Title: Procedure for the preparation of 4-phenyl butyrate and uses thereof Mar. 13, 2018
  • Patent Title: Methods of therapeutic monitoring of phenylacetic acid prodrugs Feb. 07, 2017
  • Patent Title: Methods of therapeutic monitoring of nitrogen scavenging drugs May. 03, 2016
  • Patent Title: Methods of administering and evaluating nitrogen scavenging drugs for the treatment of hepatic encephalopathy Mar. 22, 2016
  • Patent Title: Methods of therapeutic monitoring of nitrogen scavenging drugs Feb. 09, 2016
  • Patent Title: Methods of therapeutic monitoring of nitrogen scavenging drugs Aug. 04, 2015
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of HZNP in WallStreetBets Daily Discussion

HZNP News

Recent insights relating to HZNP

CNBC Recommendations

Recent picks made for HZNP stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in HZNP

Corporate Flights

Flights by private jets registered to HZNP